Participants in placebo-controlled clinical trials give informed consent to be randomized to verum or placebo. However, researchers rarely tell participants which treatment they actually received. We interviewed four participants in a trial of acupuncture for irritable bowel syndrome, before, during, and after they received a course of placebo treatments over six weeks. During the final interview, we informed participants that they had received a course of placebo treatments. We used an idiographic phenomenological approach based on the Sheffield School to describe each participant’s experiences of being blinded to and then debriefed to placebo allocation. Our participants ’ experiences of blinding and debriefing were embodied, related to t...
Background: Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effe...
Objective: To determine whether placebo responses can be explained by characteristics of the patient...
OBJECTIVES: To assess whether and how investigators of placebo controlled randomised trials inform p...
Participants in placebo-controlled clinical trials give informed consent to be randomized to verum o...
Abstract Background While full disclosure of information on placebo control in participant informati...
Placebos are an essential tool in randomised clinical trials, where they are used to control for con...
Question: Concealment is integral to placebo-controlled clinical trials and insures that participant...
Placebos are an essential tool in randomised clinical trials, where they are used to control for bia...
Abstract Background A significant proportion of trial participants respond to placebos for a variety...
Patients in the placebo arms of randomized controlled trials (RCT) often experience positive changes...
© 2018 The Author(s). Background: While full disclosure of information on placebo control in partici...
BACKGROUND: A significant proportion of trial participants respond to placebos for a variety of cond...
CONTEXT:Previous studies suggested that many patients, who have given their informed consent to part...
Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which c...
Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which c...
Background: Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effe...
Objective: To determine whether placebo responses can be explained by characteristics of the patient...
OBJECTIVES: To assess whether and how investigators of placebo controlled randomised trials inform p...
Participants in placebo-controlled clinical trials give informed consent to be randomized to verum o...
Abstract Background While full disclosure of information on placebo control in participant informati...
Placebos are an essential tool in randomised clinical trials, where they are used to control for con...
Question: Concealment is integral to placebo-controlled clinical trials and insures that participant...
Placebos are an essential tool in randomised clinical trials, where they are used to control for bia...
Abstract Background A significant proportion of trial participants respond to placebos for a variety...
Patients in the placebo arms of randomized controlled trials (RCT) often experience positive changes...
© 2018 The Author(s). Background: While full disclosure of information on placebo control in partici...
BACKGROUND: A significant proportion of trial participants respond to placebos for a variety of cond...
CONTEXT:Previous studies suggested that many patients, who have given their informed consent to part...
Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which c...
Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which c...
Background: Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effe...
Objective: To determine whether placebo responses can be explained by characteristics of the patient...
OBJECTIVES: To assess whether and how investigators of placebo controlled randomised trials inform p...